ILLUMINA, INC. Deferred Income Tax Expense (Benefit)
ILLUMINA, INC. (ILMN) reported Deferred Income Tax Expense (Benefit) of $119.00 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-12
- ILLUMINA, INC. deferred income tax expense (benefit) for the quarter ending 2016-01-03 was -$128.68M.
- ILLUMINA, INC. deferred income tax expense (benefit) for the quarter ending 2015-09-27 was $3.10M.
- ILLUMINA, INC. deferred income tax expense (benefit) for the quarter ending 2015-06-28 was $27.13M.
- ILLUMINA, INC. deferred income tax expense (benefit) for the quarter ending 2015-03-29 was $53.45M, a 57.48% increase year-over-year.
- ILLUMINA, INC. deferred income tax expense (benefit) for fiscal 2025 was $119.00M.
- ILLUMINA, INC. deferred income tax expense (benefit) for fiscal 2024 was -$117.00M.
- ILLUMINA, INC. deferred income tax expense (benefit) for fiscal 2023 was -$34.00M.
- ILLUMINA, INC. deferred income tax expense (benefit) for fiscal 2023 was -$23.00M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-28 | $119.00M 10-K · filed 2026-02-12 | ||||
| 2024-12-29 | -$117.00M 10-K · filed 2026-02-12 | ||||
| 2023-12-31 | -$34.00M 10-K · filed 2026-02-12 | ||||
| 2023-01-01 | -$23.00M 10-K · filed 2025-02-12 | ||||
| 2022-01-02 | -$76.00M 10-K · filed 2024-02-16 | ||||
| 2021-01-03 | $117.00M 10-K · filed 2023-02-17 | ||||
| 2019-12-29 | $5.00M 10-K · filed 2022-02-18 | ||||
| 2018-12-30 | -$18.00M 10-K · filed 2021-02-17 | ||||
| 2017-12-31 | $34.00M 10-K · filed 2020-02-11 | ||||
| 2017-01-01 | $7.00M 10-K · filed 2019-02-12 | $6.69M 10-K · filed 2017-02-14 | |||
| 2016-01-03 | -$128.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$125.58M derived: sum of 2 quarters · filed 2018-02-13 | -$98.45M derived: sum of 3 quarters · filed 2018-02-13 | -$45.00M 10-K · filed 2018-02-13 | -$44.95M 10-K · filed 2016-03-02 |
| 2015-09-27 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $30.23M derived: sum of 2 quarters · filed 2015-11-02 | $83.68M 10-Q · filed 2015-11-02 | $33.48M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-06-28 | $27.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $80.58M 10-Q · filed 2015-07-31 | $30.38M derived: sum of 3 quarters · filed 2017-02-14 | $29.30M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-03-29 | $53.45M 10-Q · filed 2015-05-01 | $3.25M derived: sum of 2 quarters · filed 2017-02-14 | $2.17M derived: sum of 3 quarters · filed 2017-02-14 | -$264.00K derived: sum of 4 quarters · filed 2017-02-14 | |
| 2014-12-28 | -$50.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$51.28M derived: sum of 2 quarters · filed 2017-02-14 | -$53.72M derived: sum of 3 quarters · filed 2017-02-14 | -$19.77M 10-K · filed 2017-02-14 | $99.85M 10-K · filed 2015-02-18 |
| 2014-09-28 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$3.52M derived: sum of 2 quarters · filed 2015-11-02 | $30.43M 10-Q · filed 2015-11-02 | -$3.61M derived: sum of 4 quarters · filed 2016-03-02 | |
| 2014-06-29 | -$2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $31.51M 10-Q · filed 2015-07-31 | -$2.53M derived: sum of 3 quarters · filed 2016-03-02 | -$32.34M derived: sum of 4 quarters · filed 2016-03-02 | |
| 2014-03-30 | $33.94M 10-Q · filed 2015-05-01 | -$97.00K derived: sum of 2 quarters · filed 2016-03-02 | -$29.91M derived: sum of 3 quarters · filed 2016-03-02 | -$22.04M derived: sum of 4 quarters · filed 2016-03-02 | |
| 2013-12-29 | -$34.04M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-02 | -$63.85M derived: sum of 2 quarters · filed 2016-03-02 | -$55.98M derived: sum of 3 quarters · filed 2016-03-02 | -$92.68M 10-K · filed 2016-03-02 | -$36.66M 10-K · filed 2014-02-18 |
| 2013-09-29 | -$29.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | -$21.94M derived: sum of 2 quarters · filed 2014-10-29 | -$58.64M 10-Q · filed 2014-10-29 | ||
| 2013-06-30 | $7.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$28.83M 10-Q · filed 2014-08-01 | |||
| 2013-03-31 | -$36.70M 10-Q · filed 2014-05-07 | ||||
| 2012-12-30 | -$21.70M 10-K · filed 2015-02-18 | -$27.56M 10-K · filed 2013-02-15 | |||
| 2012-01-01 | $13.02M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $15.11M derived: sum of 2 quarters · filed 2014-02-18 | $12.59M derived: sum of 3 quarters · filed 2014-02-18 | $19.23M 10-K · filed 2014-02-18 | -$24.86M 10-K · filed 2012-02-24 |
| 2011-10-02 | $2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$427.00K derived: sum of 2 quarters · filed 2011-11-04 | $6.21M 10-Q · filed 2011-11-04 | -$6.56M derived: sum of 4 quarters · filed 2013-02-15 | |
| 2011-07-03 | -$2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-10 | $4.12M 10-Q · filed 2011-08-10 | -$8.65M derived: sum of 3 quarters · filed 2013-02-15 | $2.16M derived: sum of 4 quarters · filed 2013-02-15 | |
| 2011-04-03 | $6.64M 10-Q · filed 2011-05-04 | -$6.13M derived: sum of 2 quarters · filed 2013-02-15 | $4.67M derived: sum of 3 quarters · filed 2013-02-15 | $8.06M derived: sum of 4 quarters · filed 2013-02-15 | |
| 2011-01-02 | -$12.77M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | -$1.97M derived: sum of 2 quarters · filed 2013-02-15 | $1.42M derived: sum of 3 quarters · filed 2013-02-15 | $6.08M 10-K · filed 2013-02-15 | $48.70M 10-K · filed 2011-02-28 |
| 2010-10-03 | $10.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $14.19M derived: sum of 2 quarters · filed 2011-11-04 | $18.84M 10-Q · filed 2011-11-04 | -$17.55M derived: sum of 4 quarters · filed 2012-02-24 | |
| 2010-07-04 | $3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-10 | $8.04M 10-Q · filed 2011-08-10 | -$28.36M derived: sum of 3 quarters · filed 2012-02-24 | -$21.43M derived: sum of 4 quarters · filed 2012-02-24 | |
| 2010-04-04 | $4.65M 10-Q · filed 2011-05-04 | -$31.74M derived: sum of 2 quarters · filed 2012-02-24 | -$24.82M derived: sum of 3 quarters · filed 2012-02-24 | ||
| 2010-01-03 | -$36.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | -$29.48M derived: sum of 2 quarters · filed 2012-02-24 | -$10.44M 10-K · filed 2012-02-24 | $29.70M 10-K · filed 2011-02-28 | |
| 2009-09-27 | $6.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $25.96M 10-Q · filed 2010-11-05 | |||
| 2009-06-28 | $19.04M 10-Q · filed 2010-08-04 | ||||
| 2008-12-28 | $31.53M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |